Empagliflozin-Induced Changes in Epicardial Fat The Centerpiece for Myocardial Protection?

被引：21
|
作者：
Mullens, Wilfried
Martens, Pieter
机构：
[1] Ziekenhuis Oost Limburg, Genk, Belgium
[2] Univ Hasselt, Biomed Res Inst, Fac Med & Life Sci, Hasselt, Belgium
来源：
JACC-HEART FAILURE | 2021年 / 9卷 / 08期
关键词：
CMR; epicardial adipose tissue; heart failure; myocardial fibrosis; SGLT2-inhibitors;
D O I：
10.1016/j.jchf.2021.05.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：590 / 593
页数：4
相关论文
共 50 条
  • [1] Empagliflozin-Induced Pancreatitis
    McIntire, Damon R.
    Bayne, David B.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (11) : 1158 - 1159
  • [2] Empagliflozin-Induced Pancreatitis: A Case Report Pattern
    Foster, Parker
    Jha, Pinky
    Pandit, Sarbagya
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [3] Case Report of Empagliflozin-Induced Cutaneous Polyarteritis Nodosa
    To, Derek
    Bradshaw, Scott
    Lipson, Jennifer
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2018, 22 (05) : 516 - 518
  • [4] EMPAGLIFLOZIN-INDUCED ANGIOEDEMA IN AN ELDERLY FEMALE: A CASE REPORT
    Durhman, Madelyn
    Kishore, Gehna
    Kishore, Sindhu
    Albuni, Mhd Kutaiba
    Mateo, Fernando
    Khan, Fayaz
    Ajenaghughrure, Godbless
    Hijazi, Mohamad
    Rajbhandari, Pranita
    Mallick, Shahla
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [5] Empagliflozin-induced gut microbiota alternation reduces obesity in high-fat diet-fed mice
    Shi, J.
    Qiu, H.
    Hou, N.
    Liu, Y.
    Han, F.
    Kan, C.
    Sun, X.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 27 - 28
  • [6] Myocardial ketone body oxidation contributes to empagliflozin-induced improvements in cardiac contractility in murine heart failure
    Voorrips, Suzanne Nathalie
    Palm, Constantin Laurent
    Saucedo-Orozco, Huitzilihuitl
    Mahmoud, Belend
    Schouten, Elisabeth Marloes
    Feringa, Anna M.
    Sanchez-Aguilera, Pablo I.
    Nijholt, Kirsten T.
    Yurista, Salva R.
    van Der Meer, Peter
    Sillje, Herman H. W.
    Westenbrink, B. Daan
    EUROPEAN JOURNAL OF HEART FAILURE, 2025,
  • [7] EMPAGLIFLOZIN-INDUCED EUGLYCEMIC KETOACIDOSIS IN PATIENTS UNDERGOING CARDIAC SURGERY
    Dholakia, Kush R.
    Golmai, Pouneh
    Robert, George
    Rizvi, Syed Ali
    Vianna, Lisa
    Salama, Maha
    Chestnut, Hayley
    Shamir, Shelby
    Armas, Andrea
    Telis, Raisa
    Bukberg, Phillip
    Brinster, Derek
    Patel, Nirav
    Scheinerman, S. Jacob
    CRITICAL CARE MEDICINE, 2024, 52
  • [8] Empagliflozin-Induced Fanconi Syndrome in a Patient With COVID-19
    Fernandez, Nicole
    Guez, Gilad S.
    Escasinas, Edgar R.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 741 - 741
  • [9] A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
    Fernandez Felix, Daniel A.
    Loria, Gloriana Madrigal
    Sharma, Sapna
    Sharma, Shorabh
    Arias Morales, Carlos E.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [10] Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus
    Albugami, Muneerah M.
    Ahmed, Mohammed
    Alobaid, Dhari
    SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2020, 8 (03): : 241 - 242
12345